Clinical Trials Directory

Trials / Sponsors / Eucure (Beijing) Biopharma Co., Ltd

Eucure (Beijing) Biopharma Co., Ltd

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
WithdrawnA Study to Evaluate YH001 in Combination With Toripalimab in Subjects With Advanced NSCLC and HCC
HCC, NSCLC Stage IIIB, NSCLC Stage IV
Phase 22023-06-01
UnknownStudy of YH004 (4-1BB Agonist Antibody) in Advanced Solid Tumors And Relapsed Or Refractory Non-Hodgkin Lympho
Advanced Solid Tumors, Relapsed Or Refractory Non-Hodgkin Lymphoma
Phase 12023-01-31
CompletedA Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unre
Mucosal Melanoma
Phase 22022-06-13
CompletedA Study to Evaluate the Combination of YH003, YH001 and Pembrolizumab in Subjects with Advanced Solid Tumors
Solid Tumor
Phase 12022-04-05
CompletedA Study to Assess YH002 in Combination with YH001 in Subjects with Advanced Solid Tumors
Advanced Solid Tumor
Phase 12022-02-21
CompletedA Study to Assess YH003 in Combination with Toripalimab(anti-PD-1 MAb) Injection in Patients with Cancers
Melanoma, Pancreatic Ductal Adenocarcinoma
Phase 22021-12-08
CompletedStudy of YH004 (4-1BB Agonist Antibody) in Advanced or Metastatic Malignancy
Cancer
Phase 12021-12-07
CompletedA Study to Evaluate YH003 in Subjects With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12021-08-26
CompletedA Study to Evaluate YH001 in Subjects With Advanced Solid Tumors
Advanced Solid Tumors
Phase 12021-01-26
CompletedA Study to Evaluate YH003 in Combination With Toripalimab (Anti-PD-1 mAb) in Subjects With Advanced Solid Tumo
Advanced Solid Tumors
Phase 1 / Phase 22020-08-04
CompletedA Study to Evaluate the Safety, Tolerability and How YH002 Enters, Moves Through and Exits the Body in Subject
Advanced Solid Malignancies
Phase 12020-04-22
CompletedA Study to Assess YH001 in Combination With Toripalimab Injection in Subjects With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12020-04-21